NDC 68727-712

ZEPZELCA

Lurbinectedin

ZEPZELCA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Jazz Pharmaceuticals, Inc.. The primary component is Lurbinectedin.

Product ID68727-712_1539647e-08e6-449a-86f7-0d090dbeb698
NDC68727-712
Product TypeHuman Prescription Drug
Proprietary NameZEPZELCA
Generic NameLurbinectedin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-06-15
Marketing CategoryNDA / NDA
Application NumberNDA213702
Labeler NameJazz Pharmaceuticals, Inc.
Substance NameLURBINECTEDIN
Active Ingredient Strength1 mg/mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 68727-712-01

8 mL in 1 VIAL, SINGLE-DOSE (68727-712-01)
Marketing Start Date2020-06-15
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [ZEPZELCA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ZEPZELCA
ZEPZELCA
88916468 not registered Live/Pending
PHARMA MAR, S.A.
2020-05-14
ZEPZELCA
ZEPZELCA
88848581 not registered Live/Pending
PHARMA MAR S.A.
2020-03-26
ZEPZELCA
ZEPZELCA
88848557 not registered Live/Pending
PHARMA MAR S.A.
2020-03-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.